Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate AI-09 In Participants With Glabellar Lines
Sponsor: Eirion Therapeutics Inc.
Summary
Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of AI-09, a Ready-to-Use Liquid Injectable Botulinum Toxin.
Official title: A Phase 2, Randomized, Double-blind, Vehicle-Controlled, Multi-Center Clinical Trial Study to Evaluate Ready to Use Injectable AI-09 In Participants With Glabellar Lines
Key Details
Gender
All
Age Range
20 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
68
Start Date
2025-12-03
Completion Date
2026-02
Last Updated
2026-01-07
Healthy Volunteers
No
Conditions
Interventions
AI-09 Ready Use Injectable Botulinum Toxin
AI-09 Ready Use Injectable Botulinum Toxin
Vehicle
Vehicle
Locations (5)
Center for Clinical and Cosmetic Research
Aventura, Florida, United States
Research Institute of the Southeast, Inc.
West Palm Beach, Florida, United States
Delricht Research
New Orleans, Louisiana, United States
Tennessee Clinical Research Center
Nashville, Tennessee, United States
Research Your Health
Plano, Texas, United States